Earnings Releases·Oct 30, 2026, 8:37 AM ET

IRADIMED CORPORATION — Third Quarter 2026 Earnings Summary

Q3 2026 revenue rose 14% year-over-year to $24.2 million, driven by strong growth across all segments including a record in monitor unit bookings and a 45% increase in domestic pump channel bookings.
Full-year 2026 revenue guidance was narrowed to $91.6–$93.1 million (down from $91.0–$96.0 million), while non-GAAP EPS guidance was raised to $2.07–$2.11 (up from $2.06–$2.21).
The company declared a $0.20 per share quarterly cash dividend and reported $63.3 million in cash and cash equivalents as of September 30, 2026.
Management cited the successful 3870 MR IV pump launch and manufacturing efficiencies as key drivers, projecting a $100.0 million revenue run rate with Q4 revenue guidance of $25.0–$26.5 million.